Research-use agreement required
You must actively agree before entering Revalin.
All products are strictly for research purposes only and are not intended for human consumption. These products have not been evaluated or approved by the FDA or Health Canada.
You must be 21 or older to browse this site.
Optional research details
Leaving these fields blank records that no institution or research details were provided.
This is the research-use access gate, separate from cookie consent.
By clicking Yes, you confirm you are 21 or older, are acting for lawful research purposes, and agree to our Terms of Service and Privacy Policy.
Research library
Compounds, documentation, and published papers.
A curated library of research chemical profiles and peer-reviewed literature. For qualified researchers — no marketing claims, just the work.
Latest papers
Newest research
1 paperCompound profile
GHK-CU
Gly-His-Lys(1:1)
Compound profile
GHK-CU
Gly-His-Lys(1:1)
GHK-Cu is a copper-binding tripeptide complex composed of glycyl-L-histidyl-L-lysine and copper(II). It is commonly referenced in cosmetic and laboratory literature as Copper Tripeptide-1 and is frequently studied in skin, extracellular matrix, and regenerative research contexts.
1 paperCompound profile
GLP-1/GIP/Glucagon Triple Agonist
Tyr-{Aib}-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-{α-Me-Leu}-Leu-Asp-Lys-{Lys(AEEA-γ-Glu-C20 diacid)}-Ala-Gln-{Aib}-Ala-Phe-Ile-Glu-Tyr-Leu-Leu-Glu-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-
Compound profile
GLP-1/GIP/Glucagon Triple Agonist
Tyr-{Aib}-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-{α-Me-Leu}-Leu-Asp-Lys-{Lys(AEEA-γ-Glu-C20 diacid)}-Ala-Gln-{Aib}-Ala-Phe-Ile-Glu-Tyr-Leu-Leu-Glu-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-
A synthetic long-acting peptide designed to function as a triple receptor agonist targeting GLP-1, GIP, and glucagon pathways. This class of compounds is currently under investigation for its role in metabolic regulation, including glucose handling, energy balance, and hepatic lipid dynamics in controlled research environments. Preclinical and early clinical studies suggest significant effects on body composition and liver fat modulation, positioning triple agonist peptides as an emerging area of metabolic research. For laboratory research use only. Not for human consumption.